Evidence map›Paper›PMID 26998418›Full record

ReviewAnalytical cellular pathology (Amsterdam)2016

Role of Natural Radiosensitizers and Cancer Cell Radioresistance: An Update.

Arif Malik, Misbah Sultana, Aamer Qazi, Mahmood Husain Qazi, Gulshan Parveen, Sulayman Waquar, Abdul Basit Ashraf, Mahmood Rasool

Open access · goldAbstract readReview
In one paragraph

Review in Analytical cellular pathology (Amsterdam), 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 37 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
37citing papers in PubMed, 1 pooled it
4.3field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

37 citing papers in PubMed, 1 synthesis or guideline pooled it, 88 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Radiosensitizers in Cancer Therapy: A Global Bibliometric Analysis.bioRxiv : the preprint server for biology · 2025
    Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Article
  10. Chemotherapy-Mediated Neuronal Aberration.Pharmaceuticals (Basel, Switzerland) · 2023
    Review
  11. Differential Radiomodulating Action ofAntioxidants (Basel, Switzerland) · 2022
    Article
  12. Article
  13. Article
  14. Review
  15. Review
  16. Article
  17. Review
  18. miR-183 promotes radioresistance of lung adenocarcinoma H1299 cells via epithelial-mesenchymal transition.Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologica · 2021
    Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 2 countries.

Arif MalikInstitute of Molecular Biology and Biotechnology (IMBB), The University of Lahore, Pakistan.ORCID 0000-0001-9445-8861
Misbah SultanaInstitute of Molecular Biology and Biotechnology (IMBB), The University of Lahore, Pakistan.
Aamer QaziCenter for Research in Molecular Medicine (CRiMM), The University of Lahore, Pakistan.
Mahmood Husain QaziCenter for Research in Molecular Medicine (CRiMM), The University of Lahore, Pakistan.
Gulshan ParveenInstitute of Molecular Biology and Biotechnology (IMBB), The University of Lahore, Pakistan.
Sulayman WaquarInstitute of Molecular Biology and Biotechnology (IMBB), The University of Lahore, Pakistan.
Abdul Basit AshrafUniversity College of Medicine and Dentistry, The University of Lahore, Pakistan.
Mahmood RasoolCenter of Excellence in Genomic Medicine Research (CEGMR), King Abdulaziz University, Jeddah, Saudi Arabia.
University of Lahore · PKKing Abdulaziz University · SA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cancer originates from genetic mutations accumulation. Cancer stem cells have been depicted as tumorigenic cells that can differentiate and self-renew. Cancer stem cells are thought to be resistant to conventional therapy like chemotherapy and radiation therapy. Radiation therapy and chemotherapy damage carcinomic DNA cells. Because of the ability of cancer stem cells to self-renew and reproduce malignant tumors, they are the subject of intensive research. In this review, CSCs radioresistant mechanisms which include DNA damage response and natural radiosensitizers have been summed up. Reactive oxygen species play an important role in different physiological processes. ROS scavenging is responsible for regulation of reactive oxygen species generation. A researcher has proved that microRNAs regulate tumor radiation resistance. Ionizing radiation does not kill the cancer cells; rather, IR just slows down the signs and symptoms. Ionizing radiation damages DNA directly/indirectly. IR is given mostly in combination with other chemo/radiotherapies. We briefly described here the behavior of cancer stem cells and radioresistance therapies in cancer treatment. To overcome radioresistance in treatment of cancer, strategies like fractionation modification, treatment in combination, inflammation modification, and overcoming hypoxic tumor have been practiced. Natural radiosensitizers, for example, curcumin, genistein, and quercetin, are more beneficial than synthetic compounds.

Indexed as

Combined Modality TherapyDNA DamageHumansNeoplasmsNeoplastic Stem CellsOxidative StressRadiation-Sensitizing AgentsRadiotherapyTreatment OutcomeTumor MicroenvironmentRadiation-Sensitizing Agents

Identifiers

PMID26998418
PMCPMC4779816
OpenAlexW2286779154

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.